Bronchial thermoplasty.

Area of Science:

• Pulmonology
• Medical Devices
• Interventional Pulmonology

Background:

• Severe asthma remains uncontrolled in some patients despite maximal pharmacological treatment.
• Bronchial Thermoplasty (BT) is an emerging therapy for refractory asthma.
• BT utilizes radiofrequency heat delivered via a bronchoscope to reduce airway smooth muscle.

Purpose of the Study:

• To evaluate the efficacy and safety of Bronchial Thermoplasty in patients with severe, uncontrolled asthma.
• To assess the impact of BT on asthma exacerbations, emergency visits, quality of life, and lung function (FEV1).

Main Methods:

• Review of three major clinical trials investigating Bronchial Thermoplasty.
• Analysis of follow-up data ranging from two to five years post-treatment.
• Assessment of adverse events and clinical significance of observed benefits.

Main Results:

• Bronchial Thermoplasty did not demonstrate improvement in FEV1 (Forced Expiratory Volume in 1 second).
• BT led to improvements in quality of life and reductions in asthma exacerbations and emergency hospital visits.
• Observed benefits were generally considered too small to be clinically significant.
• Long-term follow-up (2-5 years) revealed no significant adverse events related to BT.

Conclusions:

• Bronchial Thermoplasty shows potential for managing severe asthma by reducing exacerbations and improving quality of life, but lacks significant impact on lung function.
• The clinical significance of the observed benefits requires further evaluation.
• Additional large, independent randomized controlled trials and real-world data are necessary to establish the definitive role of BT in asthma management.